Skip to Main Content
Capabilities / Licensing & Tech Transfer

Licensing & Tech Transfer

Monetizing business assets.

Husch Blackwell negotiates global and regional licenses that drive revenues while allowing clients to retain ownership of intellectual property. We have licensed the development and use of novel compounds, human and animal drugs, medical devices, and biologics, as well as trademarks, trade secrets, and copyrights.

In developing comprehensive licensing strategies for emerging and larger technology companies, our attorneys take into account the unique business pressures each group faces. We also have significant experience helping clients divest assets they no longer wish to pursue.

Webinar | May 7, 2024
How AMCs Are Driving Innovation

The Husch Blackwell attorneys were fierce and tireless advocates for Virtus. In the face of aggressive actions by our competitors and FDA regulators, they developed and executed a legal plan that protected an important market for us. They have my gratitude and highest recommendation.

Tina Guilder, CEO, Virtus Pharmaceuticals